Schnabel A - Search Results

1

Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis.

Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL. Reinhold-Keller E, et al. Among authors: schnabel a. Arthritis Rheum. 1994 Jun;37(6):919-24. doi: 10.1002/art.1780370622. Arthritis Rheum. 1994. PMID: 8003065

2

Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment.

Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Schnabel A, et al. Semin Arthritis Rheum. 2003 Apr;32(5):273-84. doi: 10.1053/sarh.2002.50012. Semin Arthritis Rheum. 2003. PMID: 12701038

3

Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin.

Richter C, Schnabel A, Csernok E, De Groot K, Reinhold-Keller E, Gross WL. Richter C, et al. Among authors: schnabel a. Clin Exp Immunol. 1995 Jul;101(1):2-7. doi: 10.1111/j.1365-2249.1995.tb02268.x. Clin Exp Immunol. 1995. PMID: 7621588 Free PMC article.

4

Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.

Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL. Schnabel A, et al. Arthritis Rheum. 1995 May;38(5):633-7. doi: 10.1002/art.1780380509. Arthritis Rheum. 1995. PMID: 7748219

5

Low-dose methotrexate in rheumatic diseases--efficacy, side effects, and risk factors for side effects.

Schnabel A, Gross WL. Schnabel A, et al. Semin Arthritis Rheum. 1994 Apr;23(5):310-27. doi: 10.1016/0049-0172(94)90027-2. Semin Arthritis Rheum. 1994. PMID: 8036521 Review.

6

Effectiveness of cyclophosphamide pulse treatment in Wegener's granulomatosis.

Reinhold-Keller E, Kekow J, Schnabel A, Schwarz-Eywill M, Schmitt WH, Gross WL. Reinhold-Keller E, et al. Among authors: schnabel a. Adv Exp Med Biol. 1993;336:483-6. doi: 10.1007/978-1-4757-9182-2_87. Adv Exp Med Biol. 1993. PMID: 8296661

7

Treatment of Wegener's granulomatosis with intravenous immunoglobulin.

Richter C, Schnabel A, Csernok E, Reinhold-Keller E, Gross WL. Richter C, et al. Among authors: schnabel a. Adv Exp Med Biol. 1993;336:487-9. doi: 10.1007/978-1-4757-9182-2_88. Adv Exp Med Biol. 1993. PMID: 8296662

8

[ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 2. Diagnostic procedure].

de Groot K, Schnabel A, Gross WL. de Groot K, et al. Among authors: schnabel a. Z Rheumatol. 1995 Sep-Oct;54(5):291-302. Z Rheumatol. 1995. PMID: 8578885 Review. German.

9

Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases.

Schnabel A, Hauschild S, Gross WL. Schnabel A, et al. Int Arch Allergy Immunol. 1996 Mar;109(3):201-6. doi: 10.1159/000237238. Int Arch Allergy Immunol. 1996. PMID: 8620087 Review.

10

Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases.

Schnabel A, Reuter M, Gross WL. Schnabel A, et al. Arthritis Rheum. 1998 Jul;41(7):1215-20. doi: 10.1002/1529-0131(199807)41:7<1215::AID-ART11>3.0.CO;2-Y. Arthritis Rheum. 1998. PMID: 9663478 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters